Article Information
History
- August 18, 2022.
Article Versions
- You are currently viewing Version 1 of this article (August 18, 2022 - 07:40).
- Version 2 (September 26, 2022 - 08:43).
- Version 3 (October 24, 2022 - 15:43).
- Version 4 (November 23, 2022 - 09:01).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Claire S. Riley, MD1,*,
- Shruthi Venkatesh, BS2,*,
- Amar Dhand, MD, DPhil3,4,
- Nandini Doshi, BS2,
- Katelyn Kavak, MS5,
- Elle E. Levit, MD6,
- Christopher Perrone, MD7,
- Bianca Weinstock-Guttman, MD5,
- Erin E. Longbrake, MD, PhD6,
- MSReCOV investigators,
- Philip L. De Jager, MD, PhD1 and
- Zongqi Xia, MD, PhD2,#
- 1Multiple Sclerosis Center and the Center for Translational & Computational NeuroImmunology, Department of Neurology, Columbia University Irving Medical Center, New York, NY
- 2Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA
- 3Department of Neurology, Division of Hospital Medicine, Division of Stroke and Cerebrovascular Diseases, Brigham and Women’s Hospital, Boston, MA
- 4Harvard Medical School, Boston, MA
- 5Jacobs MS Center for Treatment, Jacobs Medical School and Biomedical Sciences, SUNY at Buffalo
- 6Department of Neurology, Yale School of Medicine, Yale University, New Haven, CT
- 7Department of Neurology, University of Pennsylvania, Philadelphia, PA
- ↵#Corresponding Author
: Zongqi Xia, MD, PhD, Department of Neurology, University of Pittsburgh, Biomedical Science Tower 3, Suite 7014, 3501 5th Avenue, Pittsburgh, PA 15260, Phone: 412-383-5377; Fax: 412-648-7233; Email: zxia1{at}post.harvard.edu
Posted August 18, 2022.
Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis
